PHK
AGIO icon

Point72 Hong Kong’s Agios Pharmaceuticals AGIO Stock Holding History

Point72 Hong Kong’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,978
Closed -$169K – 88
2022
Q3 		$169K Buy
5,978
+4,233
+243% +$114K 0.01% 1095
2022
Q2 		$39K Buy
+1,745
New +$39.4K ﹤0.01% 1421
2022
Q1 		– Sell
-1,513
Closed -$50K – 1788
2021
Q4 		$50K Buy
1,513
+1,032
+215% +$41.5K ﹤0.01% 1337
2021
Q3 		$22K Sell
481
-2,772
-85% -$134K ﹤0.01% 1679
2021
Q2 		$179K Buy
+3,253
New +$182K 0.01% 1182
2021
Q1 		– Sell
-3,899
Closed -$169K – 1757
2020
Q4 		$169K Sell
3,899
-5,737
-60% -$227K 0.01% 969
2020
Q3 		$337K Buy
+9,636
New +$422K 0.04% 359
2019
Q4 		– Sell
-867
Closed -$28K – 1127
2019
Q3 		$28K Buy
+867
New +$35.9K 0.01% 661
2019
Q1 		– Sell
-126
Closed -$6K – 1000
2018
Q4 		$6K Buy
+126
New +$7.78K ﹤0.01% 602
2018
Q3 		– Sell
-410
Closed -$35K – 860
2018
Q2 		$35K Sell
410
-43
-9% -$3.75K 0.01% 497
2018
Q1 		$37K Buy
453
+364
+409% +$28.1K 0.02% 524
2017
Q4 		$5K Sell
89
-152
-63% -$9.56K ﹤0.01% 583
2017
Q3 		$16K Sell
241
-154
-39% -$9.25K 0.01% 422
2017
Q2 		$20K Buy
395
+370
+1,480% +$18.9K 0.02% 374
2017
Q1 		$1K Buy
+25
New +$1.2K ﹤0.01% 661
2016
Q4 		– Sell
-2,700
Closed -$143K – 834
2016
Q3 		$143K Buy
2,700
+2,400
+800% +$105K 0.08% 279
2016
Q2 		$13K Buy
300
+200
+200% +$9.88K 0.02% 406
2016
Q1 		$4K Buy
+100
New +$4.28K 0.01% 462

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Point72 Hong Kong's AGIO Position: Q4 2022 in Review

Point72 Hong Kong sold out of Agios Pharmaceuticals (AGIO) in Q4 2022, closing a stake of 5,978 shares — an estimated $169K sold.

Point72 Hong Kong first reported a position in AGIO in Q1 2016 and held it in 18 quarters. The position peaked at $337K in Q3 2020. 160 funds tracked by Wall St. Rank hold AGIO as of Q4 2022.

  • Point72 Hong Kong reported no remaining Agios Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 5,978 Agios Pharmaceuticals shares in Q4 2022, an estimated $169K.
  • Point72 Hong Kong first reported a position in Agios Pharmaceuticals in Q1 2016 and held it in 18 quarters.
  • Point72 Hong Kong's Agios Pharmaceuticals position peaked at $337K in Q3 2020.
  • 160 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.